Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous and asynchronous data and how a data integration platform can improve project lifecycle data management, and collaborative data sharing.
In this webinar, you will:
•Understand the main drivers and benefits of closed processing in biopharma, including facility utilization, sustainability, cost reductions, and labor savings.
•Analyze biopharma facility design, comparing traditional layouts to innovative, modular, and ballroom-style configurations.
•Learn about industry guidance and best practices in the adoption of closed processing.
The definition of Good Laboratory Practice (GLP) is given by the Organization for Economic Co-operation and Development (OECD)…
Understanding regulatory expectations for ancillary/raw materials during development and early clinical phases can be challenging. Join in for a roadmap of current requirements, with a focus on Cell and Gene Therapies.
Vaccine Development collaboration: from Schistosomiasis to COVID-19 vaccine.
To achieve climate target goals, Life Science companies need to put sustainability at the front of business decisions.
We are developing a new way to program living cells by integrating synthetic biology, computational biology, and large AI models. We focus this platform on enabling the design and manufacture of advanced therapies.
In this webinar, you will learn how our new single-use bioreactor family can help you:
– Fulfill any process strategy, be it batch, fed-batch or perfusion
– Facilitate scalability of your upstream process
– Utilize the flexible design to reduce production costs
A wide range of novel vaccine modalities and conventional approaches are used to prevent and reduce the impact of infection. Adoption of templated manufacturing processes tailored to the specific modality can optimize and accelerate production workflows.
In this On-Demand version of the presentations, key opinion leaders from
